Results from two other recent studies suggest that expression of ER-β [51], as well as phosphorylated ER-β [52], are negative prognostic factors in pancreatic ductal adenocarcinoma. This evidence concerns the gene ESR2 and pancreatic ductal adenocarcinoma.